
A Study of Reported Factor VIII Use Around the World
Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest
Year: 2025
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest

A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia

Also Available In: Japanese A national tender is a cost-effective system for the purchase of products or services, such as

A comprehensive guide to creating and maintaining a successful contract fractionation program, from contract agreements to the fractionation process, the

Describes the manufacturing methods and characteristics of hemostatic products and their clinical indications for patients suffering with disorders.

This monograph outlines the treatment protocol used by healthcare providers in Georgia, U.S.A., as an example of a strategy to